Application of cold atmospheric plasma in pyoderma gangrenosum: a pilot study.

Objective: The application of cold atmospheric plasma (CAP) has been described as a promising therapeutic approach for wound healing. Its use in immunologically mediated wounds such as pyoderma gangrenosum (PG) has not yet been sufficiently investigated. This pilot study aimed to evaluate the effica...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Wound Care Vol. 34; no. 10; pp. 882 - 891
Autores principales: Gewiss, Caroline, Gehrdau, Kathrin, Hischke, Sandra, Zirkenbach, Franziska, Augustin, Matthias, Kirsten, Nathalia
Formato: pictorial research tables/charts randomized controlled trial Journal Article
Publicado: Mark Allen Holdings Limited Oct2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188602280&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188602280
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09690700
        H3U
      jtl: Journal of Wound Care
      issn: 09690700
      maglogo: N
    pubinfo:
      dt: Oct2025
      vid: 34
      iid: 10
      pid: 11383
      pub: Mark Allen Holdings Limited
    artinfo:
      ui:
        188602280
        188602280
        188602280
        10.12968/jowc.2024.0018
        188602280
      ppf: 882
      ppct: 9
      formats:
      tig:
        atl: Application of cold atmospheric plasma in pyoderma gangrenosum: a pilot study.
      aug:
        au:
          Gewiss, Caroline
          Gehrdau, Kathrin
          Hischke, Sandra
          Zirkenbach, Franziska
          Augustin, Matthias
          Kirsten, Nathalia
        affil: Dermatologikum Hamburg, Hamburg, Germany.
      sug:
        subj:
          Pyoderma Gangrenosum Therapy
          Plasma Gases Therapeutic Use
          Cold Therapeutic Use
          Treatment Outcomes Evaluation
          Patient Preference Evaluation
          Patient-Reported Outcomes Evaluation
          Wound Care Methods
          Human
          Female
          Male
          Middle Age
          Aged
          Pilot Studies
          Randomized Controlled Trials
          Random Assignment
          Control Group
          Treatment Duration
          Visual Analog Scaling
          Summated Rating Scaling
          Outpatients
          Wound Assessment
          Wound Measurement
          Wound Healing
          Bandages and Dressings
          Pain
          Quality of Life
          T-Tests
          Mann-Whitney U Test
          Wilcoxon Rank Sum Test
          Chi Square Test
          Fisher's Exact Test
          Analysis of Variance
          Paired T-Tests
          Effect Size
          Comparative Studies
          Correlation Coefficient
          Data Analysis Software
          Descriptive Statistics
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
          Male
      ab: Objective: The application of cold atmospheric plasma (CAP) has been described as a promising therapeutic approach for wound healing. Its use in immunologically mediated wounds such as pyoderma gangrenosum (PG) has not yet been sufficiently investigated. This pilot study aimed to evaluate the efficacy, tolerability, patient preferences, and patient-reported outcomes of CAP in PG. Method: This monocentric, open-label, randomised and controlled pilot study included patients with PG. The treatment phase lasted 12 weeks, with two CAP treatments per week (for patients in the treatment group (TG), versus patients in the control group (CG) who received standard of care only) and five documented study visits. Effects on wound status and patient experience—including pain reduction, improvement in quality of life, and perceived treatment benefit—were assessed. Results: Both the TG and the CG comprised 10 patients each. In the TG, a statistically significant reduction in fibrin coatings was observed between Visit 1 and Visit 5 (z=–2.060; p<0.025; n=6; d=0.84). While not statistically significant under the predefined threshold (a=0.025), necrosis showed a trend toward reduction (p=0.039). A significant reduction in pain was also observed between Visit 1 and Visit 5 in the TG (z=–2.03; p<0.025; n=5; d=0.91) Conclusion: The results of this pilot study suggest that CAP is a safe and well tolerated treatment option for PG, and may reduce wound pain over the course of treatment. There is evidence that CAP may have a beneficial effect on the status of the wound in PG. Double-blinded randomised controlled trials, including larger cohorts and outcome-oriented randomisation, are needed to further clarify the therapeutic potential of CAP in PG.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N